Premier Fund Managers’s Bristol-Myers Squibb BMY Stock Holding History

Premier Fund Managers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-227,500	Closed	-$13.6M	–	177
2026 Q1	$13.6M	Buy	227,500 +13,000	+6%	+$758K	0.96%	44
2025 Q4	$11.6M	Buy	+214,500	New	+$10.3M	0.67%	57
2025 Q2	–	Sell	-159,200	Closed	-$9.55M	–	174
2025 Q1	$9.55M	Sell	159,200 -27,100	-15%	-$1.58M	0.36%	61
2024 Q4	$10.4M	Buy	186,300 +16,100	+9%	+$900K	0.37%	59
2024 Q3	$8.67M	Buy	+170,200	New	+$7.98M	0.31%	61
2021 Q2	–	Sell	-10,767	Closed	-$682K	–	221
2021 Q1	$682K	Sell	10,767 -219	-2%	-$13.6K	0.03%	190
2020 Q4	$680K	Sell	10,986 -149,864	-93%	-$9.22M	0.03%	208
2020 Q3	$9.63M	Buy	160,850 +128,250	+393%	+$7.72M	0.55%	52
2020 Q2	$1.92M	Buy	+32,600	New	+$1.95M	0.12%	144

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Premier Fund Managers's BMY Position: Q2 2026 in Review

Premier Fund Managers sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 227,500 shares — an estimated $13.6M sold.

Premier Fund Managers first reported a position in BMY in Q2 2020 and held it in 9 quarters. The position peaked at $13.6M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Premier Fund Managers reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Premier Fund Managers sold 227,500 Bristol-Myers Squibb shares in Q2 2026, an estimated $13.6M.
Premier Fund Managers first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 9 quarters.
Premier Fund Managers's Bristol-Myers Squibb position peaked at $13.6M in Q1 2026.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Premier Fund Managers's 13F filing for Q2 2026, filed 22 Jul 2026.